About & policies · Journal of Reproducible Health Sciences

Aims & scope

last updated 2026-08-12

Aims

The Journal of Reproducible Health Sciences publishes health research whose results are reproducible as far as the data allow. Health evidence changes what clinicians do, what programmes are funded and what regulators permit, and it is very often built on records that cannot simply be posted online. That combination — high stakes, low inspectability — is what this journal is built to change. Every submission ships the code and data behind its results, or a privacy-preserving surrogate where the records cannot be shared, and a named human editor reads and signs every decision.

Scope

Scope is empirical health research with a verifiable evidence substrate — epidemiology, public and global health, clinical and rehabilitation sciences, health data science and biostatistics, and environmental and occupational health; privacy-bound data are in scope through the declared data-restriction routes.

The second half of that sentence is deliberate. A confidentiality constraint is a fact about the data, not a verdict on the work: declared honestly, with its access route stated, it keeps a paper inside scope and sends it down the restricted-data route rather than out of the journal. What scope does require is an examinable evidence substrate — data, an analysis, a model or code that someone other than the authors could inspect.

Sections

The journal publishes as one title, with one editorial board and one shared citation record, in five named sections:

  • Epidemiology. Observational designs, causal inference from observational data, surveillance, and register-based research.
  • Public & Global Health. Population interventions, policy evaluation, health systems and services, and research in low-resource settings.
  • Clinical & Rehabilitation Sciences. Trials, physiotherapy and rehabilitation research, sleep and behavioural health, clinical measurement and diagnostic accuracy.
  • Health Data Science & Biostatistics. Electronic health records and routinely collected data, prediction models, wearables and digital health, and statistical methods applied to health questions.
  • Environmental & Occupational Health. Exposures, workplace health, and climate and health.

Sections organise the journal; they do not fragment it. A section becomes a journal of its own only if it demonstrably carries its own body of work and its own dedicated editor. Nothing is announced before both exist.

Research on people

This journal publishes research on human health: human subjects, populations and health systems. Research on people is admissible only with the approvals it required — a named ethics committee and its reference number, documented consent or a documented reason none was needed, and handling of individual-level data that respects the law it was collected under (see publication ethics).

Animal-model studies are out of scope in this first version. Reviewing them properly needs an animal-ethics and ARRIVE-reporting apparatus this journal does not run, and we would rather say so than accept work we cannot hold to the standard it deserves; such studies belong in a life-sciences venue. This is a limit we intend to revisit, not a statement about the value of the work.

Interventional studies and prospective registration

Trials and other interventional studies are in scope with prospective registration. As a condition of consideration, the study must be registered in a WHO ICTRP primary registry or ClinicalTrials.gov at or before the time of first patient consent for enrolment, and the manuscript must state the registration identifier, the registry and the registration date.

What happens with that is worth being exact about, because it is a place where journals often imply more than they do. Review checks that a registration is stated, that it is prospective against the manuscript's own dates, and that the registered primary outcome and the reported one are the same study — all from the manuscript itself. The registry entry is then checked by the editors against the registry before a decision is signed. It is not checked automatically, and we do not claim it is.

An interventional study that was not prospectively registered cannot be considered. That is a condition of consideration rather than a judgement about the topic, and a decision letter will say so in those terms — it will name the registration, not the scope.

Study protocols are not an article type here. SPIRIT 2025 is named on this page only as the reference for what a registered protocol should contain — not as an invitation to submit one.

Reporting guidelines

Submissions are expected to follow the EQUATOR-matched reporting guideline for their design, and to ship the completed checklist with the manuscript:

  • CONSORT 2025 — randomised trials.
  • STROBE — observational studies, with RECORD for studies using routinely collected health data.
  • PRISMA 2020 — systematic reviews and meta-analyses.
  • TRIPOD+AI — development and validation of clinical prediction models.
  • STARD — diagnostic-accuracy studies.
  • CHEERS 2022 — economic evaluations.

Where no listed guideline fits a design, say which one comes closest and where the study departs from it. A checklist is a way of making a paper checkable, which is the same thing this journal asks of code and data.

Systematic reviews and meta-analyses

Actively welcome, and reviewed on equal terms. A synthesis is among the most reproducible genres in health research when it travels with its search strategy, its extraction table and its analysis code — and among the least when it does not. We ask for all three, and we rerun the analysis.

What we cannot review well yet

Qualitative health research is out of scope in this first version. The reason is about us, not about the work: the review roster this journal runs is quantitative — power adequacy, statistical rigour, numerical consistency — and it would judge an interview study by criteria that do not fit it. Supporting qualitative work honestly means COREQ- and SRQR-aware guidance and a qualitative-methods reviewer profile; we would rather build that first than review such submissions badly. Mixed-methods work with a quantitative core is in scope, and its qualitative strand is reviewed for transparency of method and material, not for statistics.

Case reports are out of scope in this first version: a single clinical narrative carries no substrate this journal's verification can act on.

Privacy-bound data, and what the badge claims

Reproducibility here is a default, not a barrier. Every contribution carries a reproducibility package — an executable source, the analysis code, the data or a surrogate, a pinned environment and its determinism information — and where individual-level records cannot be released, the restriction is declared with the route by which a reader could obtain access, and an anonymised or synthetic surrogate takes the data's place wherever one can be built.

The badge then reports exactly what the check produced. ✓ Reproduced means the deposited code, over the deposited data, regenerated the results as printed. ◑ Partially reproduced means some of them did. Privacy-limited means the original records could not be released, and it is a distinct, honest state rather than a lesser one. In every case the article's reproducibility panel states in words what was verified and what was not; the badge summarises that panel and never claims more than it shows. See data & code availability for the package and the restricted-data routes.

How claims are read in review

Health papers are read against their design as well as their numbers. Review asks whether the sample and the analysis can support the conclusion drawn, whether causal language is licensed by the design or only by hope, whether the abstract's claim is the one the results establish, and whether the reporting is honest about multiplicity, missing data and the ways selection could have produced the finding. None of that is about how interesting the topic is.

Out of scope

  • Work with no examinable evidence at all: no data, no analysis, no model, no code, and no willingness to document how the results were produced. A confidentiality restriction is not a reason for exclusion; it has a route.
  • Research on people conducted without the required ethical approval, or reporting individual-level data the authors were not permitted to analyse or publish.
  • Animal-model studies, qualitative-only studies and case reports, in this first version, for the reasons given above.
  • Work with no health question behind it, and topics outside the health sciences.
  • Advocacy without evidence, and evidence assembled to reach a commissioned conclusion.

Soundness, not newsworthiness

We judge a submission on scientific soundness and reproducibility, not on novelty or how newsworthy the finding seems. A rigorous, correctly reported, reproducible study showing that an intervention did not work is in scope and publishable — and it is the kind of paper the literature is most short of, because it is the kind that is hardest to place. This is not "accept everything": the bar is rigour plus reproducibility, and that bar is real. Replications, reanalyses and null findings are welcomed deliberately.

How submissions are assessed, including the disclosed use of AI and the named human editor who signs every decision, is described in the peer-review policy. What a submission must contain is on the author guidelines page.